SQUAMOUS CELL CARCINOMA OF THE BLADDER
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for rare genitourinary cancers
Disease control Recruiting nowThis study tests whether two approved cancer drugs, sacituzumab govitecan and atezolizumab, can shrink or control rare tumors of the bladder, kidney, ureters, and penis. About 60 adults with these uncommon cancers will receive the drugs through an IV, either alone or together. Th…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for rare cancers: drug combo shows promise in early trial
Disease control Recruiting nowThis study tests whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can shrink or control rare cancers of the bladder, urinary tract, and testicles. About 68 adults with these rare tumors will receive the drugs through an IV for up to 5 years. The goal is t…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:19 UTC